The protective effect of melatonin on neural stem cell against LPS-induced inflammation

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Song, Juhyun ^a   Kang, So Mang ^a   Lee, Kyoung Min ^b   Lee, Jong Eun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MELATONIN; MESSENGER RNA; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SOX2; CELL RECEPTOR; NR2E1 PROTEIN, MOUSE; PROTECTIVE AGENT; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; EMBRYO; ENZYME ACTIVATION; FEMALE; INFLAMMATION; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL DIFFERENTIATION; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION; HUMAN; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; GENE EXPRESSION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MELATONIN; NEURAL STEM CELLS; NITRIC OXIDE; PRIMARY CELL CULTURE; PROTECTIVE AGENTS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS;

EID: 84924276073     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/854359     Document Type: Article

References (94)

1. F. Lezoualc'h, T. Skutella, M. Widmann, and C. Behl, "Melatonin prevents oxidative stress-induced cell death in hippocampal cells," NeuroReport, vol. 7, no. 13, pp. 2071-2077, 1996.
2. M.-J. Jou, T.-I. Peng, L.-F. Hsu et al., "Visualization of melatonin'smultiple mitochondrial levels of protection against mitochondrialCa 2+-mediated permeability transition and beyond in rat brain astrocytes," Journal of Pineal Research, vol. 48,no. 1, pp. 20-38, 2010.
3. J. C. Mayo, R. M. Sainz, H. Uria, I. Antolin, M. M. Esteban, and C. Rodriguez, "Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease," Journal of Pineal Research, vol. 24, no. 3, pp. 179-192, 1998.
4. Y.-M. Yoo, S.-V. Yim, S.-S. Kim et al., "Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT immortalized pineal cells," Journal of Pineal Research, vol. 33, no. 3, pp. 146-150, 2002.
5. R. J. Reiter, "Melatonin: the chemical expression of darkness," Molecular and Cellular Endocrinology, vol. 79,no. 1-3, pp.C153-C158, 1991.
6. R. Hardeland, "Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites," Cellular and Molecular Life Sciences, vol. 65, no. 13, pp. 2001-2018, 2008.
7. M. L. Dubocovich, "Melatonin receptors: role on sleep and circadian rhythmregulation," SleepMedicine, vol. 8, supplement 3, pp. 34-42, 2007.
8. J. B. Hoppe, R. L. Frozza, A. P. Horn et al., "Amyloid neurotoxicity in organotypic culture is attenuated bymelatonin: involvement ofGSK-3, tau and neuroinflammation," Journal of Pineal Research, vol. 48, no. 3, pp. 230-238, 2010.
9. G. Paradies, G. Petrosillo,V. Paradies, R. J. Reiter, and F. M. Ruggiero, "Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease," Journal of Pineal Research, vol. 48, no. 4, pp. 297-310, 2010.
10. T.Moriya, N. Horie,M.Mitome, and K. Shinohara, "Melatonin influences the proliferative and differentiative activity of neural stem cells," Journal of Pineal Research, vol. 42, no. 4, pp. 411-418, 2007.
11. A. Sotthibundhu, P. Phansuwan-Pujito, and P. Govitrapong, "Melatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zone," Journal of Pineal Research, vol. 49, no. 3, pp. 291-300, 2010.
12. H. Okano, "Stem cell biology of the central nervous system," Journal of Neuroscience Research, vol. 69, no. 6, pp. 698-707, 2002.
13. N. Uchida, D.W. Buck, D. He et al., "Direct isolation of human central nervous system stem cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 26, pp. 14720-14725, 2000.
14. D. J. H. Mathews, J. Sugarman, H. Bok et al., "Cell-based interventions for neurologic conditions: ethical challenges for early human trials," Neurology, vol. 71, no. 4, pp. 288-293, 2008.
15. L. Anderson, R. M. Burnstein, X. He et al., "Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo," Experimental Neurology, vol. 204, no. 2, pp. 512-524, 2007.
16. S.-H. Hsu, C.-H. Su, and I.-M. Chiu, "A novel approach to align adult neural stem cells on micropatterned conduits for peripheral nerve regeneration: a feasibility study," Artificial Organs, vol. 33, no. 1, pp. 26-35, 2009.
17. M. Kitazawa, S. Oddo, T. R. Yamasaki, K. N. Green, and F. M. LaFerla, "Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease," The Journal of Neuroscience, vol. 25, no. 39, pp. 8843-8853, 2005.
18. O. Micheau and J. Tschopp, "Induction of TNF receptor Imediated apoptosis via two sequential signaling complexes," Cell, vol. 114, no. 2, pp. 181-190, 2003.
19. H.-M. Gao and J.-S. Hong, "Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression," Trends in Immunology, vol. 29, no. 8, pp. 357-365, 2008.
20. A. Belmadani, P. B. Tran, D. Ren, and R. J.Miller, "Chemokines regulate themigration of neural progenitors to sites of neuroinflammation," Journal of Neuroscience, vol. 26, no. 12, pp. 3182-3191, 2006.
21. G.Martino and S. Pluchino, "The therapeutic potential of neural stem cells," Nature Reviews Neuroscience, vol. 7, no. 5, pp. 395-406, 2006.
22. C.-S. Wong, G.-M. Jow, A. Kaizaki, L.-W. Fan, and L.-T. Tien, "Melatonin ameliorates brain injury induced by systemic lipopolysaccharide in neonatal rats," Neuroscience, vol. 267, pp. 147-156, 2014.
23. M. Aparicio-Soto, C. Alarćon-de-la-Lastra, A. Ćardeno, S. ͆anchez-Fidalgo, and M. Sanchez-Hidalgo, "Melatonin modulates microsomal PGE synthase 1 and NF-E2-related factor-2-regulated antioxidant enzyme expression in LPS-induced murine peritoneal macrophages," British Journal of Pharmacology, vol. 171, no. 1, pp. 134-144, 2014.
24. G. C. Brown, "Mechanisms of inflammatory neurodegeneration: INOS andNADPH oxidase," Biochemical Society Transactions, vol. 35, no. 5, pp. 1119-1121, 2007.
25. G. C. Brown, "Nitric oxide and neuronal death," Nitric Oxide, vol. 23, no. 3, pp. 153-165, 2010.
26. M. Chen, H.-Y. Sun, S.-J. Li, M. Das, J.-M. Kong, and T.-M. Gao, "Nitric oxide as an upstream signal of p38 mediates hypoxia/reoxygenation-induced neuronal death," NeuroSignals, vol. 17, no. 2, pp. 162-168, 2009.
27. A. Bal-Price and G. C. Brown, "Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity," Journal of Neuroscience, vol. 21,no. 17,pp. 6480-6491, 2001.
28. P. J. Khandelwal, A.M. Herman, and C. E.-H.Moussa, "Inflammation in the early stages of neurodegenerative pathology," Journal of Neuroimmunology, vol. 238, no. 1-2, pp. 1-11, 2011.
29. G. C. Brown and J. J. Neher, "Inflammatory neurodegeneration and mechanisms of microglial killing of neurons," Molecular Neurobiology, vol. 41, no. 2-3, pp. 242-247, 2010.
30. M. Leist, C. Volbracht, S. Kühnle, E. Fava, E. Ferrando-May, and P. Nicotera, "Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide," Molecular Medicine, vol. 3, no. 11, pp. 750-764, 1997.
31. B. Brüne, A. vonKnethen, and K. B. Sandau, "Nitric oxide (NO): an effector of apoptosis," Cell Death and Differentiation, vol. 6, no. 10, pp. 969-975, 1999.
32. T. Uehara, Y. Kikuchi, and Y. Nomura, "Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Ycells," Journal ofNeurochemistry, vol. 72,no. 1, pp. 196-205, 1999.
33. A. A. Pieper, S. Blackshaw, E. E. Clements et al., "Poly(ADPribosyl) ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1845-1850, 2000.
34. V. Calabrese, T. E. Bates, and A. M. Giuffrida Stella, "NO synthase andNO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance," Neurochemical Research, vol. 25, no. 9-10, pp. 1315-1341, 2000.
35. A. Cheng, S. L. Chan, O.Milhavet, S.Wang, andM. P.Mattson, "p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells," The Journal of Biological Chemistry, vol. 276, no. 46, pp. 43320-43327, 2001.
36. M. Tanaka, S. Yoshida, M. Yano, and F. Hanaoka, "Roles of endogenous nitric oxide in cerebellar cortical development in slice cultures," NeuroReport, vol. 5, no. 16, pp. 2049-2052, 1994.
37. A. Vilar, L. de Lemos, I. Patraca et al., "Melatonin suppresses nitric oxide production in glial cultures by proinflammatory cytokines through p38 MAPK inhibition," Free Radical Research, vol. 48, no. 2, pp. 119-128, 2014.
38. F.Cimadamore, A. Amador-Arjona, C. Chen,C.-T. Huang, and A. V. Terskikh, "SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 32, pp. E3017-E3026, 2013.
39. M. Cavallaro, J.Mariani, C. Lancini et al., "Impaired generation ofmature neurons by neural stemcells from hypomorphic Sox2 mutants," Development, vol. 135, no. 3, pp. 541-557, 2008.
40. F. Cimadamore, K. Fishwick, E. Giusto et al., "Human ESCderived neural crest model reveals a key role for SOX2 in sensory neurogenesis," Cell Stem Cell, vol. 8, no. 5, pp. 538-551, 2011.
41. K. Arnold, A. Sarkar, M. A. Yram et al., "Sox2+ adult stem and progenitor cells are important for tissue regeneration and survival of mice," Cell Stem Cell, vol. 9, no. 4, pp. 317-329, 2011.
42. Y. Shi, D. C. Lie, P. Taupin et al., "Expression and function of orphan nuclear receptor TLX in adult neural stemcells," Nature, vol. 427, no. 6969, pp. 78-83, 2004.
43. W.Kang, L. C.Wong, S.H. Shi, and J.M.Hébert, "The transition from radial glial to intermediate progenitor cell is inhibited by FGF signaling during corticogenesis," Journal of Neuroscience, vol. 29, no. 46, pp. 14571-14580, 2009.
44. H. E. Stevens, K. M. Smith, M. E. Maragnoli et al., "Fgfr2 is required for the development of the medial prefrontal cortex and its connections with limbic circuits," Journal of Neuroscience, vol. 30, no. 16, pp. 5590-5602, 2010.
45. W. Zheng, R. S. Nowakowski, and F. M. Vaccarino, "Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone," Developmental Neuroscience, vol. 26, no. 2-4, pp. 181-196, 2004.
46. P.Moi, K. Chan, I. Asunis, A. Cao, and Y. W. Kan, "Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the globin locus control region," Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9926-9930, 1994.
47. C.W.Han, M. J. Kwun, K. H. Kimet al., "Ethanol extract of Alismatis Rhizoma reduces acute lung inflammation by suppressing NF B and activating Nrf2," Journal of Ethnopharmacology, vol. 146, no. 1, pp. 402-410, 2013.
48. Y. Mitsuishi, K. Taguchi, Y. Kawatani et al., "Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming," Cancer Cell, vol. 22, no. 1, pp. 66-79, 2012.
49. K. H. Jung, S.-W. Hong, H.-M. Zheng, D.-H. Lee, and S.-S. Hong, "Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model," Journal of Pineal Research, vol. 47, no. 2, pp. 173-183, 2009.
50. K. H. Jung, S.-W. Hong, H.-M. Zheng et al., "Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats," Journal of Pineal Research, vol. 48, no. 3, pp. 239-250, 2010.
51. J. Y. Koh and D. W. Choi, "Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay," Journal of Neuroscience Methods, vol. 20, no. 1, pp. 83-90, 1987.
52. S. K. Ahn, S. Hong, Y. M. Park, W. T. Lee, K. A. Park, and J. E. Lee, "Effects of agmatine on hypoxic microglia and activity of nitric oxide synthase," Brain Research, vol. 1373, pp. 48-54, 2011.
53. S. Hong, J. E. Lee, C. Y. Kim, and G. J. Je, "Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line," BMC Neuroscience, vol. 8, article 81, 2007.
54. M. Sajad, J. Zargan, M. A. Zargar et al., "Quercetin prevents protein nitration and glycolytic block of proliferation in hydrogen peroxide insulted cultured neuronal precursor cells (NPCs): implications on CNS regeneration," NeuroToxicology, vol. 36, pp. 24-33, 2013.
55. S. Yari, K. Parivar, M. Nabiuni, and M. Keramatipour, "Effect of embryonic cerebrospinal fluid on proliferation and differentiation of neuroprogenitor cells," Cell Journal, vol. 15, no. 1, pp. 29-36, 2013.
56. Y.-J. Chyan, B. Poeggeler, R. A. Omar et al., "Potent neuroprotective properties against the Alzheimer amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid,"TheJournal of Biological Chemistry, vol. 274, no. 31, pp. 21937-21942, 1999.
57. B. Poeggeler, R. J. Reiter, D.-X. Tan, L.-D. Chen, and L. C. Manchester, "Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis," Journal of Pineal Research, vol. 14, no. 4, pp. 151-168, 1993.
58. M. Allegra, R. J. Reiter, D.-X. Tan, C. Gentile, L. Tesoriere, and M. A. Livrea, "The chemistry of melatonin's interaction with reactive species," Journal of Pineal Research, vol. 34, no. 1, pp. 1-10, 2003.
59. C.Tomás-Zapico and A.Coto-Montes, "Aproposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes," Journal of Pineal Research, vol. 39, no. 2, pp. 99-104, 2005.
60. M. Song,Y.-J.Kim,Y.-H.Kim, J. Roh, S.U.Kim, and B.-W.Yoon, "Effects of duplicate administration of human neural stem cell after focal cerebral ischemia in the rat," International Journal of Neuroscience, vol. 121, no. 8, pp. 457-461, 2011.
61. P. Zhang, J. Li, Y. Liu et al., "Human neural stem cell transplantation attenuates apoptosis and improves neurological functions after cerebral ischemia in rats," Acta Anaesthesiologica Scandinavica, vol. 53, no. 9, pp. 1184-1191, 2009.
62. W. Wang, T. Nakayama, N. Inoue, and T. Kato, "Quantitative analysis of nitric oxide synthase expressed in developing and differentiating rat cerebellum," Developmental Brain Research, vol. 111, no. 1, pp. 65-75, 1998.
63. A. Torroglosa, M. Murillo-Carretero, C. Romero-Grimaldi, E. R.Matarredona, A. Campos-Caro, and C. Estrada, "Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway," StemCells, vol. 25, no. 1, pp. 88-97, 2007.
64. R. Covacu, A. I. Danilov, B. S. Rasmussen et al., "Nitric oxide exposure diverts neural stem cell fate from neurogenesis towards astrogliogenesis," Stem Cells, vol. 24, no. 12, pp. 2792-2800, 2006.
65. S. Gil-Perotn, M. Duran-Moreno, A. Cebrían-Silla, M. Ramrez, P. Garća-Belda, and J. M. Garća-Verdugo, "Adult neural stem cells from the subventricular zone: a review of the neurosphere assay," Anatomical Record, vol. 296, no. 9, pp. 1435-1452, 2013.
66. A. L. M. Ferri, M. Cavallaro, D. Braida et al., "Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adultmouse brain," Development, vol. 131, no. 15, pp. 3805-3819, 2004.
67. M. Bani-Yaghoub, R. G. Tremblay, J. X. Lei et al., "Role of Sox2 in the development of the mouse neocortex," Developmental Biology, vol. 295, no. 1, pp. 52-66, 2006.
68. R. Favaro, M. Valotta, A. L. Ferri et al., "Hippocampal development and neural stemcellmaintenance require Sox2-dependent regulation of Shh," Nature Neuroscience, vol. 12,no. 10, pp. 1248-1256, 2009.
69. V.Graham, J. Khudyakov, P. Ellis, andL.Pevny, "SOX2 functions to maintain neural progenitor identity," Neuron, vol. 39, no. 5, pp. 749-765, 2003.
70. M. Bylund, E. Andersson, B. G. Novitch, and J.Muhr, "Vertebrate neurogenesis is counteracted by Sox1-3 activity," Nature Neuroscience, vol. 6, no. 11, pp. 1162-1168, 2003.
71. C.-L. Zhang, Y. Zou, W. He, F. H. Gage, and R. M. Evans, "A role for adult TLX-positive neural stem cells in learning and behaviour," Nature, vol. 451, no. 7181, pp. 1004-1007, 2008.
72. G. Sun, R. T. Yu, R.M. Evans, and Y. Shi, "Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15282-15287, 2007.
73. G. Sun, K. Alzayady, R. Stewart et al., "Histone demethylase LSD1 regulates neural stem cell proliferation," Molecular and Cellular Biology, vol. 30, no. 8, pp. 1997-2005, 2010.
74. G. Sun, P. Ye, K. Murai et al., "MiR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells," Nature Communications, vol. 2, no. 1, article 529, 2011.
75. Q. Qu, G. Sun, W. Li et al., "Orphan nuclear receptor TLX activatesWnt/ catenin signalling to stimulate neural stem cell proliferation and self-renewal," Nature Cell Biology, vol. 12, no. 1, pp. 31-40, 2010.
76. T. Chadashvili and D. A. Peterson, "Cytoarchitecture of fibroblast growth factor receptor 2 (FGFR-2) immunoreactivity in astrocytes of neurogenic and non-neurogenic regions of the young adult and aged rat brain," Journal of Comparative Neurology, vol. 498, no. 1, pp. 1-15, 2006.
77. A. Kerever, J. Schnack, D. Vellinga et al., "Novel extracellular matrix structures in the neural stem cell niche capture the neurogenic factor fibroblast growth factor 2 from the extracellular milieu," Stem Cells, vol. 25, no. 9, pp. 2146-2157, 2007.
78. D. L. Coutu and J. Galipeau, "Roles of FGF signaling in stem cell self-renewal, senescence and aging," Aging, vol. 3, no. 10, pp. 920-933, 2011.
79. S. Topp, C. Stigloher, A. Z. Komisarczuk, B.Adolf, T. S. Becker, and L. Bally-Cuif, "Fgf signaling in the zebrafish adult brain: association of Fgf activity with ventricular zones but not cell proliferation," Journal of Comparative Neurology, vol. 510, no. 4, pp. 422-439, 2008.
80. K. Itoh, T. Chiba, S. Takahashi et al., "An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements," Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 313-322, 1997.
81. A. Uruno and H. Motohashi, "The Keap1-Nrf2 system as an in vivo sensor for electrophiles,"Nitric Oxide, vol. 25,no. 2, pp. 153-160, 2011.
82. K. Itoh, N. Wakabayashi, Y. Katoh et al., "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain," Genes and Development, vol. 13, no. 1, pp. 76-86, 1999.
83. J.W.Kaspar, S. K. Niture, andA. K. Jaiswal, "Nrf2:INrf2 (Keap1) signaling in oxidative stress," FreeRadical Biology andMedicine, vol. 47, no. 9, pp. 1304-1309, 2009.
84. Q. Ma, "Role of Nrf2 in oxidative stress and toxicity," Annual Review of Pharmacology and Toxicology, vol. 53, pp. 401-426, 2013.
85. Y.-J. Surh, J. K. Kundu, M.-H. Li, H.-K.Na, and Y.-N. Cha, "Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress," Archives of Pharmacal Research, vol. 32, no. 8, pp. 1163-1176, 2009.
86. E. M. Harrison, S. J.McNally, L. Devey, O. J. Garden, J. A. Ross, and S. J.Wigmore, "Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells," FEBS Journal, vol. 273, no. 11, pp. 2345-2356, 2006.
87. Y. Xu, C. Duan, Z. Kuang, Y. Hao, J. L. Jeffries, and G. W. Lau, "Pseudomonas aeruginosa pyocyanin activates NRF2-ARE-mediated transcriptional response via the ROS-EGFRPI3K-AKT/MEK-ERK MAP kinase signaling in pulmonary epithelial cells," PLoS ONE, vol. 8, no. 8,Article IDe72528, 2013.
88. G. Negi, A. Kumar, and S. S. Sharma, "Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF B and Nrf2 cascades," Journal of Pineal Research, vol. 50, no. 2, pp. 124-131, 2011.
89. E. O. Farombi and Y.-J. Surh, "Heme oxygenase-1 as a potential therapeutic target for hepatoprotection," Journal of Biochemistry and Molecular Biology, vol. 39, no. 5, pp. 479-491, 2006.
90. A.Prawan, J. K. Kundu, andY. J. Surh, "Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection," Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1688-1703, 2005.
91. M. S. Bitar and F. Al-Mulla, "A defect in nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes," The American Journal of Physiology-Endocrinology and Metabolism, vol. 301, no. 6, pp. E1119-E1129, 2011.
92. M. K. Park, C. Hee Kim, Y. M. Kim, et al., "Akt-dependent heme oxygenase-1 induction by NS-398 in C6 glial cells: a potential role for CO in prevention of oxidative damage from hypoxia," Neuropharmacology, vol. 53, no. 4, pp. 542-551, 2007.
93. M.K.Park, Y. J. Kang,Y.M.Ha et al., "EP2 receptor activationby prostaglandin E2 leads to induction of HO-1 via PKA and PI3K pathways in C6 cells," Biochemical and Biophysical Research Communications, vol. 379, no. 4, pp. 1043-1047, 2009.
94. J. E. Le Belle, N. M. Orozco, A. A. Paucar et al., "Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner," Cell Stem Cell, vol. 8, no. 1, pp. 59-71, 2011.